Trust is a crucial component for pharmaceutical manufacturers, yet it can be a challenge to build and maintain. According to (Outsourcing Pharma) only 39% of patients have faith in the pharmaceutical supply chain, compared to 44% of industry insiders, and it’s understandable why. When it comes to medicine, patient safety is always the top priority. Issues like counterfeit drugs, which account for up to 30% of medicines sold globally according to Interpol, a €400 billion (USD 438.33) shadow industry of diverted medications, and quality-related issues cause 62% of drug shortages, according to FDA data, all contribute to these trust gaps.
However, imagine a pharmaceutical world where every pill tells a story, every package has a unique ID, and you have an airtight trail from your factory to the pharmacy shelf. That’s the power of pharmaceutical serialization for peerless transparency to spot fakes, trigger lightning-fast recalls, and keep your inventory in check.
Granted, it’s not easy. Only a third of companies feel ready for U.S. serialization rules, and a mere 15% are set for EU compliance. But with the L1-L5 serialization framework, covering everything from packaging lines to global communications, you can have a tangible blueprint to transform your supply chain into a trustworthy, well-oiled machine.
Every day brings a new challenge in pharma manufacturing, and pharmaceutical serialization only adds to it. So, let’s start simplifying things by breaking down the entire pharma serialization process step by step, from L1 to L5, no frills, no fuss — just practical, actionable insights.
Device-level serialization forms the heart of your serialization efforts. Your production line transforms here, incorporating advanced printers, vision systems, and labeling machines to apply unique identifiers to each package.
The primary challenge at this level involves maintaining consistent accuracy at production speeds. Balancing the pace of your packaging line with the quality of each serialized code requires precision. Success here sets the stage for your entire serialization strategy, making investing in reliable, high-performance equipment and thorough staff training paramount.
Moving up the serialization stack, L2 focuses on controlling your packaging lines. Your aim involves implementing systems that manage the flow of serial numbers and maintain data integrity at the line level. You’ll also need to implement robust line management systems that seamlessly integrate with your L1 devices and communicate effectively with higher-level systems.
User-friendly interfaces play a key role here, allowing operators to monitor processes in real time and quickly address issues. Efficient L2 systems support compliance and optimize production rates, transforming a regulatory requirement into an operational advantage.
Now that your packaging lines are moving along, it’s time to zoom out and look at the bigger picture. L3 site-level serialization brings all your packaging lines together under one roof (figuratively speaking, of course — we know your factory already has a roof).
Think of L3 as the traffic control center for your serialization data. You’re managing data from multiple packaging lines, making sure that everything is consistent, and generating necessary reports for both internal use and regulatory compliance. Be sure that as you implement L3 serialization, consider how it will integrate with your existing Manufacturing Execution Systems (MES) and its ability to scale alongside your production.
L4 serialization is where things get really interesting. If you thought managing one site was fun, how about juggling multiple production facilities? It’s like playing 3D chess, but the pieces are made of data, and the board spans continents.
Implementing effective L4 systems allows you to standardize data across all sites, manage global serial number ranges, and integrate serialization data with your enterprise resource planning (ERP) systems. It’s about creating a single source of truth for your serialization data, providing the visibility and analytics needed for informed decision-making across your entire production network. Get this right, and you’ll have the kind of visibility across your production network that most manufacturers only dream about.
Finally, network-level serialization is the pinnacle of full-stack serialization. At this level, your internal systems connect with the broader pharmaceutical supply chain and regulatory bodies.
Your L5 systems must be capable of exchanging serialization data with trading partners, connecting to national or regional serialization repositories, and maintaining compliance with global regulations like the Drug Supply Chain Security Act (DSCSA) or the Falsified Medicines Directive (FMD). The key here is flexibility — as regulatory requirements evolve, your network-level serialization must be adaptable to these changes.
Pharmaceutical serialization has come a long way, and the future promises even more sophisticated tracking and tracing capabilities. The recent exemptions from the FDA for DSCSA compliance give trading partners additional time to implement, troubleshoot, and mature their electronic systems. That said, the time is ticking, and we are rapidly approaching this new deadline. It’s a new era of supply chain management, and pharma manufacturers need more robust and well-tested systems in place to meet these DSCSA requirements.
Globalized pharma supply chains have become extremely complex. While they offer unprecedented reach and efficiency, they also introduce new challenges in terms of regulation and security. The DSCSA mandates that manufacturers, wholesalers, and pharmacies use serialization to track and trace prescription drugs at every point in the supply chain. This requirement has spurred the development of more sophisticated serialization practices that extend beyond pharmaceuticals to areas like medication adherence, animal health, and even agriculture.
Managing international regulations and distribution in this complex domain demands peerless transparency and robust serialization systems that can adapt to diverse requirements around the globe. Take South Korea, for example. In 2024, they shifted from voluntary to mandatory disclosures, requiring companies to submit reports to their expenditure management system, KOPS. Meanwhile, Brazil and the UK are considering similar nationwide transparency schemes. And in Europe, the European Commission for the Control of Foot-and-Mouth Disease (EUFMD) has been exploring ways to enhance transparency in animal health reporting across member states, which could potentially influence broader regulatory trends in the region.
Pharma’s future hinges on L4 and L5 serialization — the real industry game-changers. L4 brings enterprise-wide integration, letting you track every pill from the factory floor to the pharmacy shelf in real time: no more data silos or blind spots. L5 then kicks it up a notch, weaving a global web of partners, customers, and regulators. Picture seamless data flow across continents, breaking down walls between systems and organizations.
The importance of these advanced serialization levels cannot be overstated, especially when working to prevent counterfeiting and diversion. By assigning unique identifiers to each product, serialization makes it significantly harder for counterfeiters to replicate legitimate products. And with L4 and L5’s eagle-eyed traceability, criminals can’t sneak products into unauthorized markets. We’re talking ironclad control over where your meds end up.
The power of serialization in pharma goes beyond slapping on barcodes — it’s a multi-layered shield against counterfeits, a compass for your supply chain, and your ticket to regulatory compliance.
Let’s first explore how each level of L1-L5 serialization contributes to meeting global regulatory requirements such as the U.S. Drug Supply Chain Security Act (DSCSA) and the EU Falsified Medicines Directive (FMD):
You’ve poured countless hours into developing a life-saving drug, only to find knockoffs flooding the market. It’s a nightmare scenario that’s all too real in this industry. Yet with full-stack serialization, you have a secret weapon on your side that can tag every single package with a unique ID that creates a digital trail from your factory floors to pharmacy shelves. Sure, wrangling all that data feels like drinking from a fire hose, but think about the payoff. You’re not just jumping through regulatory hoops; you’re building a tenable defense against the fakes that threaten everything you’ve worked for.
Beyond following rules, it’s about protecting your brand and, more importantly, your patients. When you complete serialization, you’re sending a clear message: your products are the real deal. You have genuine meds reaching patients who desperately need them, potentially saving lives from counterfeits. And let’s not forget the operational perks either – no more mysterious inventory disappearances and the benefits of pinpoint expiration date management. It’s a tall order, but if anyone’s up for the challenge, it’s the dedicated pharmaceutical manufacturers.
L1-L5 serialization significantly enhances traceability in the pharmaceutical supply chain, though it’s important to note its limitations. This system allows tracking from the manufacturer to the dispenser (typically a pharmacy), but not to the individual patient. In the U.S., most prescription medications are repackaged at the pharmacy level, so the serialization primarily covers bulk containers or cases rather than individual patient bottles.
The benefits of this system can include:
For manufacturers, this means increased visibility into your product’s journey through the supply chain, reduced uncertainty about shipment locations and delivery status to distributors. While it doesn’t provide real-time GPS-like tracking, it does offer checkpoints that can significantly improve supply chain management and security.
Every pill tells its own story in the world of L1-L5 serialization. You’ve seen the roadmap, from the nitty-gritty of device-level tagging to the bird’s-eye view of network-level data exchange. It’s a journey that can build trust and help protect your brand, patients, and bottom line.
Implementing a comprehensive serialization strategy is a complex undertaking. That’s where Systech comes in with track-and-trace solutions that can help you seamlessly integrate serialization across your production lines and supply chain. What’s more, Systech’s industry-leading expertise in meeting DSCSA and FMD requirements helps ensure you stay ahead of regulatory curves, while authentication services can provide an extra layer of protection against counterfeiting to protect both your brand and patients.
Don’t let serialization be just another compliance shortcoming. Contact Systech today to turn these challenges into opportunities for operational excellence and market leadership. Your competitors are already moving — can you afford to wait?
©2024 Systech. All rights reserved.
EN 
PT 
FR 
DE 
